Proto Labs (NYSE:PRLB) Announces Quarterly Earnings Results

Proto Labs (NYSE:PRLB) released its earnings results on Friday. The industrial products company reported $0.60 EPS for the quarter, topping the consensus estimate of $0.53 by $0.07, FiscalAI reports. The firm had revenue of $149.34 million during the quarter, compared to analysts’ expectations of $144.53 million. Proto Labs had a net margin of 4.71% and a return on equity of 4.15%. Proto Labs’s revenue for the quarter was up 10.5% on a year-over-year basis. During the same period in the previous year, the company earned $0.41 EPS. Proto Labs updated its Q3 2026 guidance to 0.560-0.640 EPS.

Here are the key takeaways from Proto Labs’ conference call:

• Record results and raised outlook: Q2 revenue reached a record $149.3 million, up 10.2% year over year in constant currency, while adjusted EPS rose 45% to $0.60. Management raised its full-year 2026 revenue-growth forecast to 8%–10%.
• Factory services drove momentum: CNC Machining revenue grew 13.1% and Injection Molding increased 12.9%, with particular strength in aerospace and defense, telecommunications, medical devices, and larger customer orders. Adjusted operating margin improved 340 basis points, supported by gross-margin expansion and operating leverage.
• Increasing production opportunity: Proto Labs said larger strategic customers are expanding relationships beyond prototyping into production, supported by certifications, quality systems, and capabilities such as traceability and process validation. The company is also evaluating acquisitions to add production capabilities in its existing service areas.
• Europe remains a profitability headwind: European revenue grew 7.3% in constant currency, but management cautioned that the region’s profitability recovery is still a medium-term work in progress despite go-to-market changes and a newly simplified commercial structure. 3D Printing revenue also declined 2.7%, primarily because of a 6.7% drop in Europe.

Proto Labs Price Performance

Proto Labs stock opened at $74.51 on Friday. The stock’s 50-day moving average is $77.00 and its 200-day moving average is $66.70. The company has a market cap of $1.77 billion, a price-to-earnings ratio of 59.61 and a beta of 1.38. Proto Labs has a 12 month low of $40.84 and a 12 month high of $83.15.

Key Headlines Impacting Proto Labs

Here are the key news stories impacting Proto Labs this week:

• Positive Sentiment: Q2 results exceeded expectations. Proto Labs reported earnings of $0.60 per share, ahead of the $0.54 consensus estimate and up from $0.41 a year earlier. Revenue reached a record $149.3 million, exceeding expectations of $144.5 million and increasing approximately 10.5% year over year. Proto Labs Q2 Earnings and Revenues Top Estimates
• Positive Sentiment: Operating momentum remained healthy. Total revenue per customer contact rose 16.7% year over year, while CNC machining revenue increased 13.6%, supporting the company’s growth profile. Protolabs Reports Financial Results for the Second Quarter of 2026
• Positive Sentiment: Q3 EPS guidance was notably above expectations. Management forecast earnings of $0.56 to $0.64 per share, compared with the $0.48 analyst consensus, implying continued earnings strength.
• Neutral Sentiment: Revenue guidance was broadly in line. The Q3 revenue outlook of $145 million to $153 million has a midpoint slightly above the $145.9 million consensus, but does not signal a major upside surprise on sales.
• Negative Sentiment: Valuation may be limiting the reaction. Proto Labs trades at roughly 70 times earnings, leaving the stock vulnerable to profit-taking when forward revenue growth is moderate, even after the quarterly beat. The company’s net margin was 4.71%, which also underscores the importance of sustained margin improvement.

Analyst Ratings Changes

PRLB has been the topic of several analyst reports. Wall Street Zen cut Proto Labs from a “strong-buy” rating to a “buy” rating in a report on Saturday, July 18th. Benchmark increased their target price on Proto Labs from $70.00 to $91.00 and gave the stock a “buy” rating in a research report on Thursday, July 2nd. Zacks Research lowered Proto Labs from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 3rd. Finally, Weiss Ratings upgraded Proto Labs from a “hold (c+)” rating to a “buy (b-)” rating in a report on Friday, July 17th. Two investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $91.00.

Insider Activity

In other news, insider Michael R. Kenison sold 16,030 shares of the business’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $69.49, for a total transaction of $1,113,924.70. Following the completion of the sale, the insider owned 18,683 shares in the company, valued at approximately $1,298,281.67. The trade was a 46.18% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Sven Wehrwein sold 2,000 shares of Proto Labs stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $77.28, for a total transaction of $154,560.00. Following the transaction, the director directly owned 32,505 shares in the company, valued at approximately $2,511,986.40. This trade represents a 5.80% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 25,663 shares of company stock worth $1,804,727 over the last ninety days. Corporate insiders own 1.30% of the company’s stock.

Institutional Trading of Proto Labs

Institutional investors have recently added to or reduced their stakes in the business. Invesco Ltd. raised its position in Proto Labs by 5.2% in the fourth quarter. Invesco Ltd. now owns 107,698 shares of the industrial products company’s stock valued at $5,448,000 after purchasing an additional 5,364 shares during the period. Summit Global Investments acquired a new stake in shares of Proto Labs in the fourth quarter valued at about $473,000. State of Tennessee Department of Treasury grew its stake in shares of Proto Labs by 82.1% in the fourth quarter. State of Tennessee Department of Treasury now owns 17,728 shares of the industrial products company’s stock valued at $933,000 after buying an additional 7,995 shares in the last quarter. Empowered Funds LLC raised its holdings in shares of Proto Labs by 4.0% during the 4th quarter. Empowered Funds LLC now owns 112,876 shares of the industrial products company’s stock valued at $5,710,000 after buying an additional 4,335 shares during the period. Finally, Zacks Investment Management purchased a new stake in shares of Proto Labs during the 4th quarter valued at about $325,000. 84.54% of the stock is owned by hedge funds and other institutional investors.

About Proto Labs

Proto Labs, Inc is a digital manufacturing company that offers on-demand production services for custom parts and prototypes. Utilizing technologies such as 3D printing (additive manufacturing), CNC machining and injection molding, the company transforms digital CAD designs into functional parts on accelerated timelines. Its platform-driven process combines automated quoting, rapid tool generation and manufacturing execution to serve product developers, engineers and small- to medium-sized production runs.

Founded in 1999 by Larry Lukis, Proto Labs has championed the application of digital workflows to traditional manufacturing methods.